Drug Shortage Report for MALARONE PEDIATRIC
Report ID | 190045 |
Drug Identification Number | 02264935 |
Brand name | MALARONE PEDIATRIC |
Common or Proper name | atovaquone and proguanil hydrochloride tablets |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | PROGUANIL HYDROCHLORIDE ATOVAQUONE |
Strength(s) | 25.0MG 62.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 12s |
ATC code | P01BB |
ATC description | ANTIMALARIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-04-17 |
Estimated end date | Unknown |
Actual end date | 2023-06-19 |
Shortage status | Resolved |
Updated date | 2023-06-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-04-21 | English | Compare |
v2 | 2023-04-21 | French | Compare |
v3 | 2023-06-21 | English | Compare |
v4 | 2023-06-21 | French | Compare |
Showing 1 to 4 of 4